Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
287
days
Targeting HDAC and proteostasis to eradicate quiescent cancer cells
AuthorsQi Jiang; Michelle Ertel; Austin Arrigo; Amjad Hijazzi; Sara Sannino; Jennifer L. Goeckeler-Fried; April Sagan; Ian Beddows; Betsy Ann Varghese; Daniel D. Brown; Wayne Stallaert; Adrian Lee; Amanda M. Clark; Hui Shen; Jeffrey L. Brodsky; Hatice U. Osmanbeyoglu; Ronald J. Buckanovich
Affiliations1. Obstetrics and Gynecology Magee-Womens Research Inst. & Foundation, Pittsburgh, USA; 2. School of Medicine, Tsinghua University, Beijing, China; 3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, USA; 4. Department of Biological Sciences, University of Pittsburgh, Pittsburgh, USA; 5. Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, USA; 6. Van Andel Institute, Grand Rapids, USA; 7. Department of Computational and Systems Biology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; 8. Department of Pharmacology, University of Pittsburgh, Pittsburgh, USA; 9. Department of Pathology, University of Pittsburgh, Pittsburgh, USA; 10. Department of Internal Medicine, UPMC Hillman Cancer Center, Pittsburgh, USA
408
days
Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer
AuthorsXin Ouyang; Xiaotong Deng; Qizhao Wang; Minghui Chu; Xinyu Wei; Mengting Wang; Chunming Xiang; Peng Zhang; Zhe Sun; Shijun Shen; Yao Xu
Affiliations1. Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan, China; 2. Department of Hepatopancreatobiliary and Minimally Invasive Surgery, the People’s Hospital of Lincang, Lincang, China; 3. Department of General Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, China; 4. College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China; 5. College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan, China
232
days
LncRNA PCAT7 drives tumorigenesis and glycolytic reprogramming in breast cancer via the ceRNA-mediated miR-204-5p/RUNX2 axis
AuthorsPengxiang Zhu; Wei Wu; Yining Han; Zhihan Yao; Rongxuan Xu; Xiaofeng Li
Affiliations1. Department of Epidemiology and Health Statistics, Dalian Medical University, Dalian, China
288
days
Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability
AuthorsRohit Sivaprasad; Kristijonas Žemaitis; David Linfeldt; Sudip Ghosh; Anne de Snaijer; Mattias Magnusson; Fredrik Ek; Jenny Hansson; Agatheeswaran Subramaniam
Affiliations1. Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden; 2. Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden; 3. Chemical Biology & Therapeutics, Lund University, Lund, Sweden
139
days
CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination
AuthorsJing Shen; Wen Zhang; Zhiqiang Chu; Lei Zhu; Yan Feng; Xuling Sun
Affiliations1. Department of Scientific Research, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 2. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shihezi University, Shihezi, PR China; 3. Department of Gastroenterology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China; 4. Xinjiang Clinical Research Center for Digestive Diseases, Urumqi, PR China
219
days
HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt signaling pathway
AuthorsJing Zhang; Qionghui Wu; Jingyuan Liu; Shisheng Li
Affiliations1. Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 3. Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, China; 4. Department of Otorhinolaryngology, Head and Neck Surgery, the Second Xiangya Hospital, Central South University, Changsha, China
184
days
Glypican-3-targeted therapy in hepatocellular carcinoma: biological insights and therapeutic strategies
AuthorsNa Li; Shurong Li; Peng Cao; Mengfan Tang; Junfeng Zhang; Wei Zhang; Jinfeng Liu; Chunping Ye; Dan Wu; Xixi Li; Li Dai; Xianglin Zuo
Affiliations1. Department of Immunology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China; 3. Department of Obstetrics and Gynecology, Nanjing Women and Children’s Healthcare Hospital, Women’s Hospital of Nanjing Medical University, Nanjing, China; 4. Department of Pathogen Biology, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China; 5. Department of Basic Medical Sciences, Jiangsu Medical College, Yancheng, China; 6. Biobank of Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China
173
days
Targeting RAB27A-mediated small extracellular vesicle secretion via CRISPR-Cas9 negatively affects proliferation and metastasis in both in vitro and in vivo SCLC models
AuthorsOnur Tokgün; Kubilay İnci; Aziz Gültekin; Büşra Çelikkaya; Nesrin İrep; Hakan Akça; Pervin Elvan Tokgün
Affiliations1. Department of Medical Genetics, Faculty of Medicine, Pamukkale University, Denizli, Turkey; 2. Department of Biology, Faculty of Science and Literature, Düzce University, Düzce, Turkey; 3. Department of Nuclear Medicine, Medical Faculty, Pamukkale University, Denizli, Turkey; 4. Department of Cancer Molecular Biology, Institution of Health Sciences, Pamukkale University, Denizli, Turkey
292
days
CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1
AuthorsYan Wang; Dajun Chen; Shuai Qian; Fengping Wang; Huibin Weng
Affiliations1. Department of Radiation Oncology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, China; 2. Department of Gastroenterology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, China; 3. Department of Clinical Laboratory, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s Hospital, Quzhou, China
217
days
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression
AuthorsNicolas Thomas Iannozzi; Paola Storti; Rosanna Vescovini; Camilla Sitzia; Andrea Poletti; Valentina Franceschi; Giannalisa Todaro; Gabriella Sammarelli; Denise Toscani; Vincenzo Raimondi; Mattia Dessena; Oxana Lungu; Fazel Mohammadi; Matteo Scita; Matia Bernardi; Anna Benedetta Dalla Palma; Stefania Ricci; Bruno Lorusso; Costanza Anna Maria Lagrasta; Federico Quaini; Luca Agnelli; Gaetano Donofrio; Nicola Giuliani
Affiliations1. Department of Medicine and Surgery, University of Parma, Parma, Italy; 2. Department of Medical-Veterinary Science, University of Parma, Parma, Italy; 3. Hematology and BMT Unit, “Azienda Ospedaliero-Universitaria di Parma”, Parma, Italy; 4. “Istituto Nazionale dei Tumori” Foundation, Milan, Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days